| Company Name: |
ShangHai Caerulum Pharma Discovery Co., Ltd.
|
| Tel: |
18149758185 |
| Email: |
sales-cpd@caerulumpharma.com |
| Products Intro: |
Product Name:trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium:iodide
CAS:3854-04-4
Purity:98% Package:10mg;100mg;1g;10g;100g;1kg
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Oxotremorine M
CAS:3854-04-4
Purity:≥98% by HPLC Remarks:Oxotremorine is a selective muscarinic acetylcholine receptor agonist. It can be used as a parasympathomimetic drug.
|
|
| | trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium:iodide Basic information |
| | trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium:iodide Chemical Properties |
| storage temp. | Desiccate at -20°C | | solubility | DMSO : 125 mg/mL (387.97 mM; Need ultrasonic) | | form | Powder | | Water Solubility | Soluble to 100 mM in water |
| | trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium:iodide Usage And Synthesis |
| Description | Oxotremorine M is a non-selective muscarinic (M) acetylcholine receptor agonist that induces phosphoinositide hydrolysis in mouse ileum isolated from wild-type, M2, M3, and M2/M3 knockout mice (EC50s = 0.36, 0.52, 1.62, and 1.48 μM, respectively). It also increases M4-induced inhibition of calcium currents in NG108-15 mouse neuroblastoma X rat glioma hybrid cells (EC50 = 0.14 μM). Oxotremorine M inhibits KCNQ2/3 potassium currents in Xenopus oocytes expressing M1 receptors and KCNQ2/3 potassium channels (IC50 = 1.1 μM). It also directly inhibits KCNQ2/3 potassium channels, decreasing KCNQ2/3 potassium currents in Xenopus oocytes lacking muscarinic receptors in a dose-dependent manner. | | Uses | Oxotremorine M is a muscarinic receptor agonist. | | storage | Desiccate at -20°C |
| | trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium:iodide Preparation Products And Raw materials |
|